Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012)

Insulet (PODD) posted Non-Current Deferred Tax Liability of $700000.0 for Q4 2012, down 30.0% on a QoQ basis from $1.0 million in Q3 2012, and down 22.22% year-over-year from $900000.0 in Q1 2012.

Insulet (PODD) Non-Current Deferred Tax Liability (2011 - 2012) Analysis & Trends

Insulet's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $700000.0 for Q4 2012.

  • Quarterly Non-Current Deferred Tax Liability fell 22.22% year-over-year to $700000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $700000.0 (down 22.22% YoY) and the FY2012 annual result came in at $700000.0, down 22.22% from the prior year.
  • Non-Current Deferred Tax Liability was $700000.0 for Q4 2012 at Insulet, down from $1.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $5.5 million in Q2 2011 and bottomed at $700000.0 in Q4 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 700,000.00
Dec 31, 2012 700,000.00
Sep 30, 2012 1.00 Mn
Sep 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Jun 30, 2012 1.00 Mn
Mar 31, 2012 900,000.00
Mar 31, 2012 900,000.00
Dec 31, 2011 900,000.00
Dec 31, 2011 900,000.00
Jun 30, 2011 5.50 Mn
Jun 30, 2011 5.50 Mn